News

Peripheral Nerve Society - Saint Malo - 29th June to 3rd July 2013

GeNeuro will present two posters.

Peripheral Nerve Society

European College of Neuropsychopharmacology - Barcelona - 5th to 9th October 2013

GeNeuro will do an oral presentation as invited speaker.

European College of Neuropsychopharmacology

18 September 2012, Plan-les-Ouates, Geneva, Switzerland - GeNeuro SA announces the launch of a phase IIa clinical study with GNbAC1, a humanized monoclonal antibody targeting a human endogenous retrovirus, to treat multiple sclerosis.

The randomized placebo-controlled phase IIa study will test single ascending doses of GNbAC1 in patients with multiple sclerosis for the first time.